Finch Therapeutics Group, Inc. (FNCHQ)
OTCMKTS
· Delayed Price · Currency is USD
6.39
+0.14 (2.24%)
Apr 29, 2026, 10:28 AM EST
Finch Therapeutics Group Market Cap
Finch Therapeutics Group has a market cap or net worth of $9.97 million as of April 29, 2026. Its market cap has decreased by -45.04% in one year.
Market Cap
9.97M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$6.39
Market Cap Chart
Since March 19, 2021, Finch Therapeutics Group's market cap has decreased from 1.01B to 9.97M, a decrease of -99.01%. That is a compound annual growth rate of -59.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 9.97M | -53.96% |
| Dec 31, 2025 | 21.66M | 19.35% |
| Dec 31, 2024 | 18.15M | 213.02% |
| Dec 29, 2023 | 5.80M | -74.79% |
| Dec 30, 2022 | 22.99M | -95.14% |
| Dec 31, 2021 | 473.36M | -52.91% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Brainstorm Cell Therapeutics | 8.50M |
| Biomind Labs | 8.14M |
| Zenith Capital | 7.99M |
| BetterLife Pharma | 7.93M |
| NKGen Biotech | 7.84M |
| HOOKIPA Pharma | 14.15M |
| Galera Therapeutics | 7.55M |
| Synlogic | 7.43M |